• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴瘤发生中的毒力受与莫洛尼鼠白血病病毒(MoMuLV)增强子的CORE和GRE-LVa元件结合的蛋白质变化的调节。

Virulence in lymphomagenesis is modulated by alterations in proteins binding to CORE and GRE-LVa elements of the MoMuLV enhancer.

作者信息

Yuen P H, Khang Y H, Matherne C

机构信息

University of Texas System Cancer Center, Science Park-Research Division, Smithville 78957.

出版信息

Leukemia. 1992;6 Suppl 3:76S-82S.

PMID:1602832
Abstract

Changing nucleotide 3 of the CORE consensus from T to C has no effect on the binding of a 42 kDa protein, which has little affinity for the CCAAT binding site. Changing nucleotide 6 of the CORE consensus from T to C significantly reduces binding of the 42 kDa protein. Studies on the pathology induced by various MoMuLV mutants with CORE mutations showed that the CORE elements are important in modulating virulence in T-cell lymphomagenesis in BALB/c mice. However, disease specificity appears to be influenced as much by the host as it is by the virus. LVa is preferentially bound to the GRE-LVa sites. Deletion of nucleotide 9 and changing nucleotides 10 and 11 from GG to AA in the GRE-LVa element does not disrupt binding of LVa. Changing nucleotide 10 from G to A and nucleotide 13 from A to T in the GRE-LVa element does not disrupt binding of GR but allows binding of a novel protein which displaces or abolishes binding of LVa. These five nucleotide changes alone do not alter disease specificity and had a minimal effect on virulence in T-cell lymphomagenesis in BALB/c mice. Additionally, changing nucleotide 3 in CORE(a) and nucleotide 6 in CORE(b) does not alter disease specificity but has a small additional effect on virulence in T-cell lymphomagenesis.

摘要

将核心共有序列的第3位核苷酸由T变为C,对一种42 kDa蛋白的结合没有影响,该蛋白对CCAAT结合位点的亲和力很低。将核心共有序列的第6位核苷酸由T变为C,显著降低了42 kDa蛋白的结合。对具有核心突变的各种莫洛尼鼠白血病病毒(MoMuLV)突变体诱导的病理学研究表明,核心元件在调节BALB/c小鼠T细胞淋巴瘤发生中的毒力方面很重要。然而,疾病特异性似乎受到宿主的影响与受到病毒的影响一样大。LVa优先结合到GRE-LVa位点。在GRE-LVa元件中删除第9位核苷酸并将第10和11位核苷酸从GG变为AA,不会破坏LVa的结合。将GRE-LVa元件中的第10位核苷酸从G变为A以及第13位核苷酸从A变为T,不会破坏GR的结合,但允许一种新蛋白结合,该新蛋白取代或消除LVa的结合。仅这五个核苷酸变化不会改变疾病特异性,并且对BALB/c小鼠T细胞淋巴瘤发生中的毒力影响最小。此外,改变CORE(a)中的第3位核苷酸和CORE(b)中的第6位核苷酸不会改变疾病特异性,但对T细胞淋巴瘤发生中的毒力有微小的额外影响。

相似文献

1
Virulence in lymphomagenesis is modulated by alterations in proteins binding to CORE and GRE-LVa elements of the MoMuLV enhancer.淋巴瘤发生中的毒力受与莫洛尼鼠白血病病毒(MoMuLV)增强子的CORE和GRE-LVa元件结合的蛋白质变化的调节。
Leukemia. 1992;6 Suppl 3:76S-82S.
2
A single mutation in one of the CORE elements of Moloney murine leukemia virus reduced binding of a 42-kDa T lymphoma cell nuclear factor but did not affect lymphomagenesis.
Mol Carcinog. 1990;3(2):93-102. doi: 10.1002/mc.2940030207.
3
The Moloney murine leukemia virus enhancer and its flanking sequences collaborate to determine virulence in T-cell lymphomagenesis.
Mol Carcinog. 1991;4(1):72-80. doi: 10.1002/mc.2940040111.
4
The reduced virulence of the thymotropic Moloney murine leukemia virus derivative MoMuLV-TB is mapped to 11 mutations within the U3 region of the long terminal repeat.嗜胸腺性莫洛尼鼠白血病病毒衍生物MoMuLV-TB的毒力降低定位于长末端重复序列U3区域内的11个突变。
J Virol. 1989 Feb;63(2):471-80. doi: 10.1128/JVI.63.2.471-480.1989.
5
Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity.莫洛尼鼠白血病病毒增强子核心或相邻的LVb元件发生突变会改变疾病特异性。
Genes Dev. 1990 Feb;4(2):233-42. doi: 10.1101/gad.4.2.233.
6
Mutation of all Runx (AML1/core) sites in the enhancer of T-lymphomagenic SL3-3 murine leukemia virus unmasks a significant potential for myeloid leukemia induction and favors enhancer evolution toward induction of other disease patterns.致T淋巴细胞性SL3-3鼠白血病病毒增强子中所有Runx(AML1/核心)位点的突变揭示了诱导髓系白血病的巨大潜力,并有利于增强子向诱导其他疾病模式的方向进化。
J Virol. 2004 Dec;78(23):13216-31. doi: 10.1128/JVI.78.23.13216-13231.2004.
7
The role of viral enhancer "core" motif-related sequences in regulating T cell receptor-gamma and -delta gene expression.病毒增强子“核心”基序相关序列在调节T细胞受体γ和δ基因表达中的作用。
J Immunol. 1993 May 1;150(9):3905-16.
8
Differential expression of subspecies of polyomavirus and murine leukemia virus enhancer core binding protein, PEBP2, in various hematopoietic cells.多瘤病毒和鼠白血病病毒增强子核心结合蛋白PEBP2的亚群在各种造血细胞中的差异表达。
Jpn J Cancer Res. 1992 Jul;83(7):714-22. doi: 10.1111/j.1349-7006.1992.tb01971.x.
9
Loss of Fas/Apo-1 receptor accelerates lymphomagenesis in E mu L-MYC transgenic mice but not in animals infected with MoMuLV.Fas/Apo-1受体缺失会加速EμL-MYC转基因小鼠的淋巴瘤发生,但在感染莫洛尼鼠白血病病毒(MoMuLV)的动物中则不会。
Oncogene. 1995 Jun 15;10(12):2397-401.
10
Enhancer mutations of Akv murine leukemia virus inhibit the induction of mature B-cell lymphomas and shift disease specificity towards the more differentiated plasma cell stage.Akv鼠白血病病毒的增强子突变可抑制成熟B细胞淋巴瘤的诱导,并使疾病特异性向更分化的浆细胞阶段转变。
Virology. 2007 May 25;362(1):179-91. doi: 10.1016/j.virol.2006.12.016. Epub 2007 Jan 29.

引用本文的文献

1
Novel insights into the pathogenesis of the Graffi murine leukemia retrovirus.对格拉菲小鼠白血病逆转录病毒发病机制的新见解。
J Virol. 2006 Apr;80(8):4026-37. doi: 10.1128/JVI.80.8.4026-4037.2006.